Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Washington, District of Columbia 20016


Purpose:

The purpose of this study is to explore the possible cognitive effects of darifenacin modified release and long-acting oxybutynin.


Criteria:

Inclusion Criteria: - Males and females aged 60 and over - United States English as a primary language - Given written informed consent by signing and dating an informed consent form prior to study entry Exclusion Criteria: - Current diseases in which the use of anti-cholinergic drugs is contraindicated, including the use of drugs with anti-cholinergic effects - Volunteers with history of urinary retention or current bladder outlet obstruction, as determined by the investigator Other protocol defined inclusion/exclusion criteria may apply. - Current use of drugs known to effect memory and cognition Other protocol-defined inclusion/exclusion criteria may apply


NCT ID:

NCT00170768


Primary Contact:

Study Chair
Novartis
East Hanover NJ


Backup Contact:

N/A


Location Contact:

Washington, District of Columbia 20016
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.